Differentiating and Quantifying Two Different Amorphous Phases of a Drug Substance in Tablet Formulation by 15 N Solid-State NMR: Derisking the Drug’s Chemical Liability
Molecular Pharmaceutics · 06.07.2026 · 23 (7) · 3512-3518
DOI: 10.1021/acs.molpharmaceut.5c00869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 02.06.2026. Verfasst von Ales Medek und 4 weiteren Autor:innen. Beteiligte Einrichtung: Engineering and Materials Science, Vertex Pharmaceuticas, Boston, Massachusetts 02210, United States. Hauptthemen laut MEDLINE: Tablets. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Engineering and Materials Science, Vertex Pharmaceuticas, Boston, Massachusetts 02210, United States.
- Analytical Development, Vertex Pharmaceuticals, Boston, Massachusetts 02210, United States.
- Formulation Development, Vertex Pharmaceuticals, Boston, Massachusetts 02210, United States.
ORCID-Profile: Ales Medek
Zitieren
APA
Medek, A., Strohmeier, M., Schuchart, A., Maguire, C. K., & Ferris, L. (2026). Differentiating and Quantifying Two Different Amorphous Phases of a Drug Substance in Tablet Formulation by 15 N Solid-State NMR: Derisking the Drug’s Chemical Liability. Molecular Pharmaceutics, 23(7), 3512-3518. https://doi.org/10.1021/acs.molpharmaceut.5c00869
Vancouver
Medek A, Strohmeier M, Schuchart A, Maguire CK, Ferris L. Differentiating and Quantifying Two Different Amorphous Phases of a Drug Substance in Tablet Formulation by 15 N Solid-State NMR: Derisking the Drug’s Chemical Liability. Molecular Pharmaceutics. 2026;23(7):3512-3518. doi:10.1021/acs.molpharmaceut.5c00869
BibTeX
@article{Medek2026,
author = {Medek, Ales and Strohmeier, Mark and Schuchart, Andrew and Maguire, Courtney K and Ferris, Lori},
title = {Differentiating and Quantifying Two Different Amorphous Phases of a Drug Substance in Tablet Formulation by 15 N Solid-State NMR: Derisking the Drug’s Chemical Liability},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {7},
pages = {3512--3518},
doi = {10.1021/acs.molpharmaceut.5c00869}
}
EUVIMED